CRLBF (CRLBF) Stock Price & Analysis
CRLBF (CRLBF) fell 4.08% to USD 0.68 as of July 25, 2026 at 05:24 UTC, according to Nexqual real-time market data.
CRLBF last closed at USD 0.71; the session ranged USD 0.67–0.7 on volume of 44,936 shares. Market capitalization is $252.31M, with a 52-week range of USD 0.54–2.3 (OQX). Source: Nexqual, July 25, 2026 at 05:24 UTC.
Key Statistics (as of July 25, 2026 at 05:24 UTC)
| Price | USD 0.68 |
|---|---|
| Change | ▼ 4.08% (down) |
| Previous Close | USD 0.71 |
| Open | USD 0.7 |
| Day Range | USD 0.67 – 0.7 |
| 52-Week Range | USD 0.54 – 2.3 |
| Volume | 44,936 shares |
| Market Cap | $252.31M |
| Exchange | OQX |
Technical Analysis (CRLBF)
Nexqual's technical model rates CRLBF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 05:24 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.9 (oversold) |
| vs SMA50 | Below (USD 0.83) |
| MACD | -0.04 (negative) |
Analyst Ratings (CRLBF)
Wall Street analysts rate CRLBF "Strong Buy" based on 1 analysts, with a mean price target of USD 2 (range USD 2–2), per Nexqual as of July 25, 2026 at 05:24 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 2 |
| High Target | USD 2 |
| Low Target | USD 2 |
| Buy / Hold / Sell | 6 / 0 / 0 |
Earnings (CRLBF)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD -0.04 |
| Revenue Estimate | $166.20M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.04 vs est -0.04 ▲ beat |
| 2025-12-31 | USD -0.03 vs est -0.03 ▲ beat |
| 2025-09-30 | USD 0.01 vs est -0.04 ▲ beat |
| 2025-06-30 | USD -0.02 vs est -0.04 ▲ beat |
Source: Nexqual, July 25, 2026 at 05:24 UTC.
Financials & Fundamentals (CRLBF)
| Total Revenue | $641.41M |
|---|---|
| Revenue Growth (YoY) | -8.70% |
| Gross Margin | +50.11% |
| Operating Margin | +7.38% |
| Profit Margin | -20.90% |
| ROE | -45.77% |
| Debt / Equity | 240.28 |
| Current Ratio | 2.51 |
| Total Cash | $32.34M |
| Total Debt | $586.78M |
| Free Cash Flow | $-23.94M |
Source: Nexqual, July 25, 2026 at 05:24 UTC.
Financial Health Score (CRLBF)
Nexqual rates CRLBF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 05:24 UTC.
| Growth | Weak — Revenue -9% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 50%, operating 7% |
| Balance Sheet | Weak — $32M cash vs $587M debt |
| Cash Flow | Weak — FCF negative: -$24M, burning cash |
| Efficiency | Critical — ROE -46%, ROA 3.6% |
Ownership (CRLBF)
| Insider Ownership | +2.06% |
|---|---|
| Institutional Ownership | +3.51% |
| Shares Outstanding | 354.23M |
| Float | 345.56M |
Source: Nexqual, July 25, 2026 at 05:24 UTC.
Leadership (CRLBF)
CRLBF is led by Charles Bachtell (age 45), Co-Founder, CEO & Director, per Nexqual as of July 25, 2026 at 05:24 UTC.
| Co-Founder, CEO & Director | Charles Bachtell (age 45) |
|---|---|
| President | Gregory Butler (age 44) |
| Co-Founder & Independent Director | Robert M. Sampson (age 49) |
| Chief Financial Officer | Sharon Schuler (age 53) |
| Chief Operating Officer | Ty Gent (age 66) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GTBIF | Green Thumb Industries Inc. | USD 7.02 | ▼ 0.64% |
| TRLV | Trulieve Cannabis Corp. Subordi | USD 8.36 | ▼ 3.58% |
| JUSHF | Jushi Holdings Inc. | USD 0.4 | ▼ 8.05% |
| GRWG | GrowGeneration Corp. | USD 1.38 | ▲ 0% |
| OGI | Organigram Global Inc. | USD 0.93 | ▲ 1.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:24 UTC. This page is informational and not investment advice.